Federal Judge Upholds $21.06 Million Sulindac Verdict

Clinoril/sulindac

Federal Judge Upholds $21.06 Million Verdict in Sulindac Case

CONCORD, N.H. - A $21.06 million verdict issued in favor of a sulindac plaintiff was not unreasonable and was supported by sufficient evidence, New Hampshire federal judge has ruled. Bartlett v. Mutual Pharmaceutical Company Inc., No. CV-08-358-JL (D. N.H.).

On Jan. 5, Judge Joseph N. Laplante of the U.S. District Court for the District of New Hampshire denied Mutual Pharmaceutical's request for a new trial, ruling that the plaintiff's experts were qualified to testify about the drug's risks and benefits and that her defective design claim was not preempted by …